Lynde C - Search Results

1

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. Among authors: lynde c. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

2

Incorporating biologics into the treatment of psoriasis.

Lui H, Langley R, Poulin Y, Gupta AK, Carey W, Guenther L, Searles G, Toole J, Lynde C, Gulliver W, Barber K. Lui H, et al. Among authors: lynde c. J Cutan Med Surg. 2004 Aug;8 Suppl:8-13. doi: 10.1007/s10227-004-2003-6. J Cutan Med Surg. 2004. PMID: 15655584 Review. No abstract available.

3

The use of alefacept in the treatment of psoriasis.

Langley R, Gupta AK, Poulin Y, Guenther L, Barber K, Gulliver W, Lynde C. Langley R, et al. Among authors: lynde c. J Cutan Med Surg. 2004 Aug;8 Suppl:14-8. doi: 10.1007/s10227-004-2004-5. J Cutan Med Surg. 2004. PMID: 15655585 Review. No abstract available.

4

Use of pimecrolimus cream 1% (Elidel) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcome.

Eichenfield LF, Lucky AW, Langley RG, Lynde C, Kaufmann R, Todd G, Lindsley L, Barbier N, Felser JM. Eichenfield LF, et al. Among authors: lynde c. Int J Dermatol. 2005 Jan;44(1):70-5. doi: 10.1111/j.1365-4632.2004.02234.x. Int J Dermatol. 2005. PMID: 15663667 Clinical Trial.

5

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.

Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, Toole J, Zip C. Papp KA, et al. Among authors: lynde c. J Cutan Med Surg. 2006;9 Suppl 1:26-32. doi: 10.1007/s10227-006-0104-0. J Cutan Med Surg. 2006. PMID: 16633859 Review.

6

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches.

Langley RG, Ho V, Lynde C, Papp KA, Poulin Y, Shear N, Toole J, Zip C. Langley RG, et al. Among authors: lynde c. J Cutan Med Surg. 2006;9 Suppl 1:18-25. doi: 10.1007/s10227-006-0103-1. J Cutan Med Surg. 2006. PMID: 16633860 Review.

7

Efalizumab: integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis.

Lynde C. Lynde C. J Cutan Med Surg. 2006;9 Suppl 1:1-3. doi: 10.1007/s10227-006-0100-4. J Cutan Med Surg. 2006. PMID: 16633863

8

Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.

Draelos ZD, Carter E, Maloney JM, Elewski B, Poulin Y, Lynde C, Garrett S; United States/Canada Dapsone Gel Study Group. Draelos ZD, et al. Among authors: lynde c. J Am Acad Dermatol. 2007 Mar;56(3):439.e1-10. doi: 10.1016/j.jaad.2006.10.005. Epub 2007 Jan 17. J Am Acad Dermatol. 2007. PMID: 17208334 Clinical Trial.

9

Development and validation of a comprehensive acne severity scale.

Tan JK, Tang J, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Tan JK, et al. Among authors: lynde c. J Cutan Med Surg. 2007 Nov-Dec;11(6):211-6. doi: 10.2310/7750.2007.00037. J Cutan Med Surg. 2007. PMID: 18042334

10

Prevalence and severity of facial and truncal acne in a referral cohort.

Tan JK, Tang J, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Tan JK, et al. Among authors: lynde c. J Drugs Dermatol. 2008 Jun;7(6):551-6. J Drugs Dermatol. 2008. PMID: 18561586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters